沙库巴曲缬沙坦联合阿托伐他汀对高血压患者血压变异性的影响

  • 打印
  • 收藏
收藏成功


打开文本图片集

Effect of sacubactril valsartan combined with atorvastatinon bloodpresurevariabilityin patients with hypertensionZhong Jiaoyan,Yao Yaling,Lin Zhiyang.Departmentof Pharmacy, (Shanghai Sixth People's , Fujian ), Fujian 3622OO,China

【Abstract】ObjectiveTo analyze the efect of sacubactril valsartan combined with atorvastatin on blood pressurevariabilityin patients with essential hypertension.MethodsPatients withhypertension who received treatment inour hospital from June2O21 to June 2O24 were selectedas the study objects.Randomized number method was used to divide the patients into 2 groups.Forty patients in the conventional group were treated with sacubactril valsartan,and 4O patients in the combined group were treated with sacubactril valsartancombined with atorvastatin.The therapeuticefects of the two groups were analyzed.ResultsAfter 3 months of treatment, the blood pressure variability of the combined group was lower than that of the conventional group( P (204号 0.05).ConclusionPatients with hypertension were treatedwith sacubactril valsartancombined with atorvastatin caneffectively reduce thevariabilityof bloodpressure,improve thevascular elastic functionof patients,and reduce the risk of cardiovascularand cerebrovascular diseases.Compared with single medication,there is no significant changein adverse drug reactions,andclinical drug safetyis high and the application value is significant.

【Key words】 Essential hypertension; Valsartan;Pharmacotherapy, joint;Blood pressure variability: Atorvastatin

高血压是一种全球范围内发病率较高的慢性疾病,数据显示,全球高血压的发病率为 11.9% ,并且中国的高血压患病率也呈上升趋势,严重威胁着人们的健康与生命[1]。(剩余11110字)

monitor